Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - OTHER CURRENT LIABILITIES
Other Current Liabilities ALNY - Alnylam Pharmaceuticals, Inc.
713 M
LAST VALUE
34.32%
2 YEAR CAGR
43.72%
5 YEAR CAGR
46.87%
10 YEAR CAGR